Immunomedics(IMMU)

Victor_向死而生2019-12-26 23:01

$Immunomedics(IMMU)$ Morris Plains, N.J., Dec. 26, 2019 --- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the U.S. Food and Drug Administration (FD...查看全文

JZee2019-11-21 00:52

$Immunomedics(IMMU)$ 昨天那个投资会讲啥了，透了啥时候报FDA的口风么？查看全文

Replix锐璞美股2019-10-07 09:49

$Immunomedics(IMMU)$ IMMU三阴性乳腺癌的新药令人期待，不过审批过程可能比较纠结，请看我们新的估值分析，网页链接。
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐璞-Yang @美股医药Z博士 @药师老庙 @conkers查看全文

飞冲天2019-10-05 09:26

$Immunomedics(IMMU)$ Avoro Capital又买入150万股，这是死磕IMMU啊查看全文

conkers2019-09-14 02:45

$Immunomedics(IMMU)$ 这是有好消息？查看全文

旭日待东升2019-09-11 09:09

不得不说，近年FDA局长新官上任的这三把火，烧的投资者们胆战心惊啊。很多好公司的NDA都被意外CRL了，如$Heron疗法(HRTX)$ $Immunomedics(IMMU)$ 。但是好公司就是好公司，不会因为FDA换局长数据就变差，快与FDA沟通沟通，期待你们的再次爆发。查看全文

牛唐2019-09-11 07:41

三大压舱票，两只都已腾飞 $Immunomedics(IMMU)$ $Zogenix(ZGNX)$ 查看全文

格林银斯特2019-08-16 22:48

$Immunomedics(IMMU)$ 这叫什么，每况愈下...查看全文

郁闷的鞋套-2019-08-08 17:36

$Immunomedics(IMMU)$ 有些慢： Resubmission of Biologics License Application on Track for Early Fourth Quarter 2019查看全文

飞冲天2019-07-04 23:13

$Immunomedics(IMMU)$ IMMU基本从ASCO大会上$西雅图遗传学(SGEN)$ Enfortumab Vedotin更好的ORR数据恢复过来。两者的efficacy是差不多的，使用的群体有区分：不到20%的膀胱癌患者有FGFR3突变，这是Enfortumab Vedotin的优势；Enfortumab Vedotin加重过往铂类化疗患者周围神经病变，这将是Sacituzum...查看全文

云顶新耀-B(01952)与吉利德附属订立终止及过渡服务协议 总代价最高约4.55亿美元

智通财经APP讯，云顶新耀-B(01952)发布公告，于2022年8月15日，公司、Everest Medicines II及Everest SG(各自为公司的全资附属公司)与Immunomedics(吉利德的全资附属公司)订立终止及过渡服务协议，各订约方已有条件同意完成交易，总代价... 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117808  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117809  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117872  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117876  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117810  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117811  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117812  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-20-117815  Act: 33  Size: 37 KB 网页链接

$Immunomedics(IMMU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-117803  Size: 11 KB 网页链接

$Immunomedics(IMMU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-117805  Size: 8 KB 网页链接